(Q41649228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Is BRIEF a useful instrument in day to day care of patients with phenylketonuria? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Annet Bosch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Stephan C Huijbregts

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Geertje B Liemburg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Rianne Jahja

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Francjan J van Spronsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Jaap J van der Meere

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Carla E M Hollak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

M Estela Rubio-Gozalbo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Martijn C G J Brouwers

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Floris C Hofstede

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Maaike C de Vries

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Mirian C H Janssen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Ans T van der Ploeg

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Janneke G Langendonk

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

1 reference

12 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

425-430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25541101%20AND%20SRC:MED&resulttype=core&format=json

Phenylketonuria: a 21st century perspective

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Behaviour in early treated phenylketonuria: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Phenylketonuria in adulthood: a collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Stability of blood phenylalanine levels and IQ in children with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Executive function in early-treated phenylketonuria: profile and underlying mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

White matter integrity and executive abilities in individuals with phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Relationships between cognitive and behavioral measures of executive function in children with brain disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Timing is everything: executive functions in children exposed to elevated levels of phenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Preliminary neuropsychological test results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Statistical methods for assessing agreement between two methods of clinical measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Normal development of brain circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302

Executive functioning and speed of processing in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2014.12.302